Alogliptin and Protonix drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Alogliptin (alogliptin benzoate) and Protonix (pantoprazole sodium). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Alogliptin and Protonix. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Alogliptin?
Alogliptin has active ingredients of alogliptin benzoate. eHealthMe is studying from 1,943 Alogliptin users. Check the latest studies of Alogliptin.
What is Protonix?
Protonix has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 132,658 Protonix users. Check the latest studies of Protonix.
14 people who take Alogliptin and Protonix together, and have interactions are studied.

What are the common drug interactions of Alogliptin and Protonix, by gender? *:
female:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
- Acute respiratory failure
- Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
- Aortic valve disease
- Cardiac failure
- Cardiac failure acute
- Cardiac failure congestive
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
male:
- Chronic kidney disease
- Renal disorder (kidney disease)
- Urinary tract infection
- Cellulitis (infection under the skin)
- Groin infection (infection in groin)
- Hepatic infection
- Renal failure (kidney dysfunction)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Sepsis (a severe blood infection that can lead to organ failure and death)
What are the common drug interactions of Alogliptin and Protonix, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Leukocytosis (increased white blood cells)
- Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
- Renal injury (kidney injury)
- Renal tubular necrosis (death of kidney tubules)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Urinary tract infection
- Cellulitis (infection under the skin)
- Groin infection (infection in groin)
50-59:
- Chronic kidney disease
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
60+:
- Chronic kidney disease
- Renal disorder (kidney disease)
- Cardiac failure acute
- Cardiac failure congestive
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Constipation
- Mitral valve incompetence (inefficient heart valve)
- Renal failure (kidney dysfunction)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Nephrogenic anaemia (anaemia due to kidney disease)
What are the existing conditions these people have? *
- Pain: 5 people, 35.71%
- High Blood Pressure: 5 people, 35.71%
- Diabetes: 5 people, 35.71%
- High Blood Cholesterol: 4 people, 28.57%
- Type 2 Diabetes: 3 people, 21.43%
- Nephropathy (damage to or disease of a kidney): 2 people, 14.29%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 14.29%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 14.29%
- Diarrhea: 2 people, 14.29%
- Anaemia (lack of blood): 2 people, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Alogliptin and Protonix?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Alogliptin (1,943 reports)
- Protonix (132,658 reports)
Browse all drug interactions of Alogliptin and Protonix:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Alogliptin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Protonix:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Alogliptin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Protonix and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on alogliptin benzoate and pantoprazole sodium (the active ingredients of Alogliptin and Protonix, respectively), and Alogliptin and Protonix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Isoniazid cause Jaundice Cholestatic? - now
- Could Tylenol cause Cerebral Oedema? - 2 seconds ago
- Drug interactions of Trikafta and Seroquel - 4 seconds ago
- Drug interactions of Centrum and Pramine - 6 seconds ago
- Drug interactions of Centrum Silver and Azor - 6 seconds ago
- Could Prograf cause White Blood Cell Count Increased? - 6 seconds ago
- Could Xigris cause Cardiac Arrest? - 8 seconds ago
- Could Prolia cause Left Ventricular Hypertrophy? - 9 seconds ago
- Could Daypro cause Deep Venous Thrombosis? - 11 seconds ago
- Drug interactions of Dulcolax and Catapres - 16 seconds ago